The Cell and Protein Technologies Platform conducts research and development activities in the fields of vaccine technologies, particularly cancer vaccines, cell-based approaches, and antigen delivery systems designed to enhance immunological efficacy. Within the scope of the platform, studies focus on the development of novel vaccine strategies for different diseases and organisms, as well as innovative carrier systems that strengthen immune responses. Positioned within Boğaziçi CT³’s targeted therapy technologies framework, the platform aims to contribute both to scientific knowledge generation and to translational research processes extending toward clinical application.

For communication and further information, you may contact us via [email protected]